Skip to Main Content

Author Details

Reanne Bowlby
2015
27
21
PMIDPaper TitleJournal TitlePublished Year
37551834A high-throughput pipeline for DNA/RNA/small RNA purification from tissue samples for sequencing.Biotechniques2023
37551834A high-throughput pipeline for DNA/RNA/small RNA purification from tissue samples for sequencing.Biotechniques2023
35691590Whole-genome and transcriptome analysis enhances precision cancer treatment options.Ann Oncol2022
35691590Whole-genome and transcriptome analysis enhances precision cancer treatment options.Ann Oncol2022
33148671Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers.Clin Cancer Res2021
33148671Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers.Clin Cancer Res2021
32577165Tumor microRNA profile and prognostic value for lymph node metastasis in oral squamous cell carcinoma patients.Oncotarget2020
32747824Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes.Nat Genet2020
32577165Tumor microRNA profile and prognostic value for lymph node metastasis in oral squamous cell carcinoma patients.Oncotarget2020
35121966Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes.Nat Cancer2020
35121966Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes.Nat Cancer2020
32747824Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes.Nat Genet2020
31433971The Immune Landscape of Cancer.Immunity2019
31708418Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration.Cell Rep2019
31433971The Immune Landscape of Cancer.Immunity2019
31708418Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration.Cell Rep2019
28912017Indoleamine 2,3-Dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and Is Associated With Type II Hypersensitivity/Autoimmunity.Gastroenterology2018
28912017Indoleamine 2,3-Dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and Is Associated With Type II Hypersensitivity/Autoimmunity.Gastroenterology2018
29925010The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.Cell Rep2018
30322867Integrative Molecular Characterization of Malignant Pleural Mesothelioma.Cancer Discov2018
29898407Integrated Molecular Characterization of Testicular Germ Cell Tumors.Cell Rep2018
29625048Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.Cell2018
29622466Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.Cancer Cell2018
29622464A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.Cancer Cell2018
29617669The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.Cell Rep2018
29617660Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Cell Rep2018
29438696The Integrated Genomic Landscape of Thymic Epithelial Tumors.Cancer Cell2018
29925010The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.Cell Rep2018
29898407Integrated Molecular Characterization of Testicular Germ Cell Tumors.Cell Rep2018
30322867Integrative Molecular Characterization of Malignant Pleural Mesothelioma.Cancer Discov2018
29617669The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.Cell Rep2018
29617660Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Cell Rep2018
29438696The Integrated Genomic Landscape of Thymic Epithelial Tumors.Cancer Cell2018
29625048Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.Cell2018
29622466Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.Cancer Cell2018
29622464A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.Cancer Cell2018
28658632Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Cell Rep2017
28658632Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Cell Rep2017
28403581Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.Oncotarget2017
28297679Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Cell Rep2017
28292439Integrated Molecular Characterization of Uterine Carcinosarcoma.Cancer Cell2017
28403581Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.Oncotarget2017
28297679Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Cell Rep2017
28292439Integrated Molecular Characterization of Uterine Carcinosarcoma.Cancer Cell2017
26095338Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas.Gastric Cancer2016
27036018miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.Oncotarget2016
26095338Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas.Gastric Cancer2016
26536169Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.N Engl J Med2016
26536169Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.N Engl J Med2016
27036018miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.Oncotarget2016
  • 1 - 50 of 54

Recommended Authors

Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 6
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 11
Michael Bockmayr
Institute of Pathology, Charite Universitatsmedizin Berlin
Career Start Year 2013
Number of shared co-authors 3
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 10
Larissa A Pikor
Ottawa Hospital Research Institute
Career Start Year 2010
Number of shared co-authors 1
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2010
Number of shared co-authors 4
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 55
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 9
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 4
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 7
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 4
Samuel S Freeman
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 37
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 29
Markus Riester
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 4
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 10
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 7
Bin Feng
The First Affiliated Hospital of Jinan University
Career Start Year 2004
Number of shared co-authors 27
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 3
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 27
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 33
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 42
Fengshen Kuo
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 7
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 16
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 30
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 34
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 7
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 6
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 101
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 6

Collaborators

Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 14
Andrew D Cherniack
Dana-Farber Cancer Institute
Co-authored papers 14
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Co-authored papers 14
Andrew J Mungall
Co-authored papers 13
Steven J M Jones
University of British Columbia
Co-authored papers 11
Marco A Marra
University of British Columbia
Co-authored papers 10
Hui Shen
Van Andel Institute
Co-authored papers 10
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 10
Richard A Moore
Co-authored papers 10
Peter W Laird
Van Andel Institute
Co-authored papers 10
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 8
Yussanne Ma
Co-authored papers 8
Akinyemi I Ojesina
University of Alabama at Birmingham
Co-authored papers 7
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Denise Brooks
Co-authored papers 7
Vesteinn Thorsson
Institute for Systems Biology
Co-authored papers 6
Sara Sadeghi
Co-authored papers 6
Eric Chuah
Co-authored papers 6
David A Wheeler
Baylor College of Medicine
Co-authored papers 6
Joshua M Stuart
University of California at Santa Cruz
Co-authored papers 6
Chandra Sekhar Pedamallu
Broad Institute
Co-authored papers 6
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Tara M Lichtenberg
Co-authored papers 5
Toshinori Hinoue
Co-authored papers 5
Kristen Leraas
Nationwide Children's Hospital
Co-authored papers 5
Jean Claude Zenklusen
National Cancer Institute
Co-authored papers 5
Jacqueline E Schein
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 4
Jay Bowen
Nationwide Children's Hospital
Co-authored papers 4
Christina Yau
University of California San Francisco
Co-authored papers 4
Ina Felau
National Cancer Institute
Co-authored papers 4
Release 1.2